Sengenics Video Library

Featured Video : Advances in Precision Medicine in Lupus and Rheumatoid Arthritis by Myles Lewis

Other Videos

The Human Immune System as a Source of Biomarkers by Geoff Dance
Sengenics Corporate Overview
Sengenics KREX technology for biomarker discovery, patient stratification and companion diagnostics
KREX Protein Array Workflow
Sengenics p53 OncoREX Cancer Array launch seminar
SEROMAX Instruction Video
ImmuSAFE COVID+ Biochip Test
ImmuSAFE COVID+ Biochip Test for Vaccine Screening
ImmuSAFE COVID+ Biochip Test for Seroprevalence Studies


High-throughput autoantibody profiling against 1600+ proteins

Quantification of autoantibodies to 200+ clinically relevant CT antigens

Simultaneous screening of 100+
wild-type and mutant p53

Multi-antigen, multi-domain
COVID-19 antibody test

Sengenics - Functional Proteomics | Krex Technology | Protein Microarray Supplier

Sengenics, a functional proteomics company, leverages its patented KREX protein folding technology to discover autoantibody biomarker signatures for drug response prediction, patient stratification and development of CDx. Our technology ensures that all microarray proteins are full-length, correctly folded and functional, enabling specific and quantitative antibody binding to conformational epitopes.

Copyright 2008 – 2021 Sengenics All rights reserved | Sengenics Corporation LLC. Registered in Delaware, USA no. 5739583 | Sengenics UK Registered in England and Wales no. 12889389